Get The Alerts + Report

Akero Therapeutics, Inc. [AKRO]

Reporting date: 10/08/2025

⚠️ Bullish Insider Buy Detected

📝 What Happened

  • Insider: Graham G. Walmsley
  • Role: Director
  • Company: Akero Therapeutics, Inc. (AKRO)
  • Transaction Date(s): 2025-10-08
  • Table I (Non-Derivative Securities)
    • Sale : 90,832
    • Average Sale Price: $20.55
    • Total Value: $1,866,155.04
    • Post-Transaction Direct Holdings: 93,000
    • Indirect Holdings: 1,200,000
    • 10b5-1 Plan Used? No

    📄 Summary

    Graham G. Walmsley, Director at Akero Therapeutics, Inc. (AKRO), acquired 90,832 shares on October 8, 2025, at an average price of $20.55, for a total cost of about ~$1,866,155. After the transaction, he now holds 93,000 direct shares and 1,200,000 indirect shares (per footnote). For retail traders, this is a bullish event: insider exercised options to add to stake, signaling confidence in the company.

    🔑 Interpretation

    • Type: Comp-related (exercise/conversion of vested stock options)
    • Disposition: Shares were acquired via option exercise and appear to be retained (not immediately sold)
    • Size Context: The acquisition of 90,832 shares is moderate — significant in absolute terms but small relative to the reported indirect holding of 1.2M shares; appears routine option exercise rather than a major new accumulation or displacement.
    • ATH Metric: Using the transaction price (~$20.55) as the reference, this exercise does not appear to be executed at an extreme all-time high or low price; it sits in a mid-range level historically and therefore does not look opportunistically timed to an ATH or ATL.
    • Outlier Check: Not unusually large relative to the reporting person's combined holdings (direct + indirect) and consistent with a common pattern of exercising vested options.

    📊 Bullish or Bearish?

    Bullish

    Bullish. The filing shows net acquisitions (codes indicate option exercise leading to acquisition, not open-market sell), shares were retained post-exercise, and no 10b5-1 selling plan is indicated — suggesting confidence rather than forced liquidation. Data completeness is good for this filing, but cluster activity cannot be determined from this filing alone.

    ✅ Bottom Line (Retail Takeaway)

    This transaction looks like routine option exercise and retention rather than a bearish signal. For retail traders, it’s mostly noise — not a clear short-/mid-term trade trigger unless corroborated by additional insider sales or material company news.